Clinical Trial

A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease

Name: A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease — clinical trial record (NCT07717346)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HALITE-1

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

An open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease

Trial Details

NCT Number	NCT07717346
Lead Sponsor	Krystal Biotech, Inc.
Conditions	Hailey Hailey Disease, Skin Diseases, Lesion Skin
Enrollment	7 participants
Start Date	2026-05-06
Primary Completion	2026-11 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-21